List of Chapters/Sections(Table Of Content)
1 Study Coverage
1.1 Durvalumab Product Introduction
1.2 Market by Type
1.2.1 Global Durvalumab Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 2.4mL Injection
1.2.3 10mL Injection
1.3 Market by Application
1.3.1 Global Durvalumab Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Locally Advanced Urothelial Carcinoma
1.3.3 Metastatic Urothelial Carcinoma
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Durvalumab Sales Estimates and Forecasts 2017-2028
2.2 Global Durvalumab Revenue Estimates and Forecasts 2017-2028
2.3 Global Durvalumab Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Durvalumab Sales by Region
2.4.1 Global Durvalumab Sales by Region (2017-2022)
2.4.2 Global Sales Durvalumab by Region (2023-2028)
2.5 Global Durvalumab Revenue by Region
2.5.1 Global Durvalumab Revenue by Region (2017-2022)
2.5.2 Global Durvalumab Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Durvalumab Sales by Manufacturers
3.1.1 Global Top Durvalumab Manufacturers by Sales (2017-2022)
3.1.2 Global Durvalumab Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Durvalumab in 2021
3.2 Global Durvalumab Revenue by Manufacturers
3.2.1 Global Durvalumab Revenue by Manufacturers (2017-2022)
3.2.2 Global Durvalumab Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Durvalumab Revenue in 2021
3.3 Global Durvalumab Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Durvalumab Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Durvalumab Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Durvalumab Sales by Type
4.1.1 Global Durvalumab Historical Sales by Type (2017-2022)
4.1.2 Global Durvalumab Forecasted Sales by Type (2023-2028)
4.1.3 Global Durvalumab Sales Market Share by Type (2017-2028)
4.2 Global Durvalumab Revenue by Type
4.2.1 Global Durvalumab Historical Revenue by Type (2017-2022)
4.2.2 Global Durvalumab Forecasted Revenue by Type (2023-2028)
4.2.3 Global Durvalumab Revenue Market Share by Type (2017-2028)
4.3 Global Durvalumab Price by Type
4.3.1 Global Durvalumab Price by Type (2017-2022)
4.3.2 Global Durvalumab Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Durvalumab Sales by Application
5.1.1 Global Durvalumab Historical Sales by Application (2017-2022)
5.1.2 Global Durvalumab Forecasted Sales by Application (2023-2028)
5.1.3 Global Durvalumab Sales Market Share by Application (2017-2028)
5.2 Global Durvalumab Revenue by Application
5.2.1 Global Durvalumab Historical Revenue by Application (2017-2022)
5.2.2 Global Durvalumab Forecasted Revenue by Application (2023-2028)
5.2.3 Global Durvalumab Revenue Market Share by Application (2017-2028)
5.3 Global Durvalumab Price by Application
5.3.1 Global Durvalumab Price by Application (2017-2022)
5.3.2 Global Durvalumab Price Forecast by Application (2023-2028)
6 North America
6.1 North America Durvalumab Market Size by Type
6.1.1 North America Durvalumab Sales by Type (2017-2028)
6.1.2 North America Durvalumab Revenue by Type (2017-2028)
6.2 North America Durvalumab Market Size by Application
6.2.1 North America Durvalumab Sales by Application (2017-2028)
6.2.2 North America Durvalumab Revenue by Application (2017-2028)
6.3 North America Durvalumab Market Size by Country
6.3.1 North America Durvalumab Sales by Country (2017-2028)
6.3.2 North America Durvalumab Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Durvalumab Market Size by Type
7.1.1 Europe Durvalumab Sales by Type (2017-2028)
7.1.2 Europe Durvalumab Revenue by Type (2017-2028)
7.2 Europe Durvalumab Market Size by Application
7.2.1 Europe Durvalumab Sales by Application (2017-2028)
7.2.2 Europe Durvalumab Revenue by Application (2017-2028)
7.3 Europe Durvalumab Market Size by Country
7.3.1 Europe Durvalumab Sales by Country (2017-2028)
7.3.2 Europe Durvalumab Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Durvalumab Market Size by Type
8.1.1 Asia Pacific Durvalumab Sales by Type (2017-2028)
8.1.2 Asia Pacific Durvalumab Revenue by Type (2017-2028)
8.2 Asia Pacific Durvalumab Market Size by Application
8.2.1 Asia Pacific Durvalumab Sales by Application (2017-2028)
8.2.2 Asia Pacific Durvalumab Revenue by Application (2017-2028)
8.3 Asia Pacific Durvalumab Market Size by Region
8.3.1 Asia Pacific Durvalumab Sales by Region (2017-2028)
8.3.2 Asia Pacific Durvalumab Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Durvalumab Market Size by Type
9.1.1 Latin America Durvalumab Sales by Type (2017-2028)
9.1.2 Latin America Durvalumab Revenue by Type (2017-2028)
9.2 Latin America Durvalumab Market Size by Application
9.2.1 Latin America Durvalumab Sales by Application (2017-2028)
9.2.2 Latin America Durvalumab Revenue by Application (2017-2028)
9.3 Latin America Durvalumab Market Size by Country
9.3.1 Latin America Durvalumab Sales by Country (2017-2028)
9.3.2 Latin America Durvalumab Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Durvalumab Market Size by Type
10.1.1 Middle East and Africa Durvalumab Sales by Type (2017-2028)
10.1.2 Middle East and Africa Durvalumab Revenue by Type (2017-2028)
10.2 Middle East and Africa Durvalumab Market Size by Application
10.2.1 Middle East and Africa Durvalumab Sales by Application (2017-2028)
10.2.2 Middle East and Africa Durvalumab Revenue by Application (2017-2028)
10.3 Middle East and Africa Durvalumab Market Size by Country
10.3.1 Middle East and Africa Durvalumab Sales by Country (2017-2028)
10.3.2 Middle East and Africa Durvalumab Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Medimmune (AstraZeneca)
11.1.1 Medimmune (AstraZeneca) Corporation Information
11.1.2 Medimmune (AstraZeneca) Overview
11.1.3 Medimmune (AstraZeneca) Durvalumab Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Medimmune (AstraZeneca) Durvalumab Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Medimmune (AstraZeneca) Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Durvalumab Industry Chain Analysis
12.2 Durvalumab Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Durvalumab Production Mode & Process
12.4 Durvalumab Sales and Marketing
12.4.1 Durvalumab Sales Channels
12.4.2 Durvalumab Distributors
12.5 Durvalumab Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Durvalumab Industry Trends
13.2 Durvalumab Market Drivers
13.3 Durvalumab Market Challenges
13.4 Durvalumab Market Restraints
14 Key Findings in The Global Durvalumab Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
